<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4F1D2F3A-756D-4BC2-9E81-091D0356FECB"><gtr:id>4F1D2F3A-756D-4BC2-9E81-091D0356FECB</gtr:id><gtr:name>TAP Biosystems</gtr:name><gtr:address><gtr:line1>York Way</gtr:line1><gtr:line2>Royston</gtr:line2><gtr:line3>Herts</gtr:line3><gtr:postCode>SG8 5WY</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20A7D9B9-9D83-49FA-9E48-AB596B9E1D7D"><gtr:id>20A7D9B9-9D83-49FA-9E48-AB596B9E1D7D</gtr:id><gtr:name>International Stem Cell Forum (ISCF)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0B739936-E847-4D0C-8C2A-AE0C504D9F9A"><gtr:id>0B739936-E847-4D0C-8C2A-AE0C504D9F9A</gtr:id><gtr:name>Lausanne University</gtr:name><gtr:address><gtr:line1>Lausanne University</gtr:line1><gtr:line2>Dorigny</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/EDB67137-AF95-475C-954C-8EA1517069D6"><gtr:id>EDB67137-AF95-475C-954C-8EA1517069D6</gtr:id><gtr:name>Nat Inst for Bio Standards and Control</gtr:name><gtr:address><gtr:line1>Blanche Lane</gtr:line1><gtr:line2>South Mimms</gtr:line2><gtr:line4>Potters Bar</gtr:line4><gtr:line5>Hertfordshire</gtr:line5><gtr:postCode>EN6 3QG</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EDB67137-AF95-475C-954C-8EA1517069D6"><gtr:id>EDB67137-AF95-475C-954C-8EA1517069D6</gtr:id><gtr:name>Nat Inst for Bio Standards and Control</gtr:name><gtr:address><gtr:line1>Blanche Lane</gtr:line1><gtr:line2>South Mimms</gtr:line2><gtr:line4>Potters Bar</gtr:line4><gtr:line5>Hertfordshire</gtr:line5><gtr:postCode>EN6 3QG</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4F1D2F3A-756D-4BC2-9E81-091D0356FECB"><gtr:id>4F1D2F3A-756D-4BC2-9E81-091D0356FECB</gtr:id><gtr:name>TAP Biosystems</gtr:name><gtr:address><gtr:line1>York Way</gtr:line1><gtr:line2>Royston</gtr:line2><gtr:line3>Herts</gtr:line3><gtr:postCode>SG8 5WY</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20A7D9B9-9D83-49FA-9E48-AB596B9E1D7D"><gtr:id>20A7D9B9-9D83-49FA-9E48-AB596B9E1D7D</gtr:id><gtr:name>International Stem Cell Forum (ISCF)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0B739936-E847-4D0C-8C2A-AE0C504D9F9A"><gtr:id>0B739936-E847-4D0C-8C2A-AE0C504D9F9A</gtr:id><gtr:name>Lausanne University</gtr:name><gtr:address><gtr:line1>Lausanne University</gtr:line1><gtr:line2>Dorigny</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/90619E0F-9D1E-4F2E-98BB-8A8BC8E11BB9"><gtr:id>90619E0F-9D1E-4F2E-98BB-8A8BC8E11BB9</gtr:id><gtr:firstName>Glyn</gtr:firstName><gtr:otherNames>Nigel</gtr:otherNames><gtr:surname>Stacey</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_qA137914"><gtr:id>0B7DA97E-FACB-452F-8F6D-F746FF8FE8DD</gtr:id><gtr:title>Stem cell bank</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_qA137914</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>10882885</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>TAP Biosystems</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>ESNATS</gtr:description><gtr:id>F2B2B315-83D2-4708-AF22-DC0C43BE3A53</gtr:id><gtr:impact>Publication : P DeSousa, S Mcrae and G Stacey Pluripotent stem cells as cellular product for regenerative medicine. In : Regenerative Medicine , In: Pluripotent Stem Cells and the Liver. Ed. D Hay , Science Publishers (2012 in press).</gtr:impact><gtr:outcomeId>cC7DiCeEEj9-1</gtr:outcomeId><gtr:partnerContribution>Development of scale up and preservation protocols
Development of differentiation protocols</gtr:partnerContribution><gtr:piContribution>Comparison and validation of different stem cell differentiation protocols to obtain different neuronal cell types</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Stem Cell Forum (ISCF)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>International Stem Cell Banking Initiative</gtr:description><gtr:id>9E72CFD5-E0A1-4892-A7A0-C1252B7FA587</gtr:id><gtr:impact>Consensus on best practice in the procurement banking testing and release of hESC lines (2009)
Andrews et al., (2015) Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications. Regenerative Medicine. 10 (02s) doi: 10.2217/RME.14.93 
Stacey GN. (in press) Stem Cell Banking: A Global Overview. In: Stem Cell Banking: Methods and Protocols, Human Press, Springer Science +Business Media LLC, USA.</gtr:impact><gtr:outcomeId>WRmpnyo4P5u-1</gtr:outcomeId><gtr:partnerContribution>Consensus on best opractice (Andrews et al., Stem Cell Reports and Revs , Dec 2009). Stem cell bank self evaluation procedures (Stacey et al., Cell Stem Cell 2013). managing research data from stem cell lines (Isasi et al., Regen Med, 2012).</gtr:partnerContribution><gtr:piContribution>Led coordination of scientists and regulators from more than 20 countries and compiled reports and draft publications</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Stem Cell Forum (ISCF)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:department>International Stem Cell Initiative</gtr:department><gtr:description>International Stem Cell Banking Initiative</gtr:description><gtr:id>AB07EF6B-0E53-4070-9ECD-2B6C7DD0103F</gtr:id><gtr:impact>Consensus on best practice in the procurement banking testing and release of hESC lines (2009)
Andrews et al., (2015) Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications. Regenerative Medicine. 10 (02s) doi: 10.2217/RME.14.93 
Stacey GN. (in press) Stem Cell Banking: A Global Overview. In: Stem Cell Banking: Methods and Protocols, Human Press, Springer Science +Business Media LLC, USA.</gtr:impact><gtr:outcomeId>WRmpnyo4P5u-2</gtr:outcomeId><gtr:partnerContribution>Consensus on best opractice (Andrews et al., Stem Cell Reports and Revs , Dec 2009). Stem cell bank self evaluation procedures (Stacey et al., Cell Stem Cell 2013). managing research data from stem cell lines (Isasi et al., Regen Med, 2012).</gtr:partnerContribution><gtr:piContribution>Led coordination of scientists and regulators from more than 20 countries and compiled reports and draft publications</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Lausanne</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>ESNATS</gtr:description><gtr:id>2601D418-7CA4-4BCD-94C9-A09BB6DAAD9A</gtr:id><gtr:impact>Publication : P DeSousa, S Mcrae and G Stacey Pluripotent stem cells as cellular product for regenerative medicine. In : Regenerative Medicine , In: Pluripotent Stem Cells and the Liver. Ed. D Hay , Science Publishers (2012 in press).</gtr:impact><gtr:outcomeId>cC7DiCeEEj9-2</gtr:outcomeId><gtr:partnerContribution>Development of scale up and preservation protocols
Development of differentiation protocols</gtr:partnerContribution><gtr:piContribution>Comparison and validation of different stem cell differentiation protocols to obtain different neuronal cell types</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Stem Cell Forum (ISCF)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>International Stem Cell Initiative</gtr:description><gtr:id>108C641C-3B4F-41E1-9B03-6CA3006BBEF3</gtr:id><gtr:impact>Three publications in In Vitro (2010) and Nat Biotech (2007 and 2012)
Stacey GN. (in press) Stem Cell Banking: A Global Overview. In: Stem Cell Banking: Methods and Protocols, Human Press, Springer Science +Business Media LLC, USA.</gtr:impact><gtr:outcomeId>ScD7F5jaTAb-1</gtr:outcomeId><gtr:partnerContribution>three publications in In Vitro (2010) and Nature Biotech 2007 and in press</gtr:partnerContribution><gtr:piContribution>Carried out characterisation testing, supplied stockc of antibodies, crried out independednt qualification of poor performing media</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>ESNATS</gtr:description><gtr:id>77B28450-8362-4692-B7C4-22A7BC77FBF7</gtr:id><gtr:impact>Publication : P DeSousa, S Mcrae and G Stacey Pluripotent stem cells as cellular product for regenerative medicine. In : Regenerative Medicine , In: Pluripotent Stem Cells and the Liver. Ed. D Hay , Science Publishers (2012 in press).</gtr:impact><gtr:outcomeId>cC7DiCeEEj9-3</gtr:outcomeId><gtr:partnerContribution>Development of scale up and preservation protocols
Development of differentiation protocols</gtr:partnerContribution><gtr:piContribution>Comparison and validation of different stem cell differentiation protocols to obtain different neuronal cell types</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Presentations at scientific meetings</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E6C0BF10-7D67-4C8B-B407-31EED7AF48F8</gtr:id><gtr:impact>Presentations more numerous than can be listed here. c30-50 presetnations per year at various scientific meetings including International Society for Stem Cell Reseaerch, UK Nat Stem Cell Network, MRC and BBSRC grant holders meetings, commercial conferences. Summaries given in Annual Reports available of UKSCB website

Ongoing invitations to attend scientific meetings</gtr:impact><gtr:outcomeId>ir5ZxqC5p1h</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hope not hype: open evening</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>ACDA5058-2179-4BF1-A3FF-0CD74B189F5D</gtr:id><gtr:impact>Local residents around NIBSC invited to a series of presentations by UKSCB staff stem cell scientists and ethicists

Positive feedback from residents on role of UKSCB</gtr:impact><gtr:outcomeId>m8pcoSa35Xh</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cafe Scientific BishopsStrotford</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>35F03470-4A76-4F1C-AD05-FFD39124CAA5</gtr:id><gtr:impact>Presentation by UKSCB Director on stem cells and UKSCB role
Active engagement in dosucssion ran on after formal end of session

Requested further talks by NIBSC scientists</gtr:impact><gtr:outcomeId>AoauSuKTUv6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UKSCB Open Forum</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3710073C-4BAC-4BFD-9E11-4FD25789E5A2</gtr:id><gtr:impact>c50-100 attendees at UK National Stem Cell Network sessions run by UKSCB latterly run as a technical forum to engage researchers in the hESC and iPSC field

New contacts re potential UKSCB users</gtr:impact><gtr:outcomeId>r8cHSymgHU9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2009,2010,2013,2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>480718</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Alternative testing cluster SEURAT-1 (Scr&amp;amp;Tox)</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>6576EA98-C090-45F3-93CE-A8018ACD815F</gtr:id><gtr:outcomeId>hjs94bt6E950</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>126000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EC FP7 ESNATS</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>9A73F434-EDBA-4C8E-BC69-81DE66814BB5</gtr:id><gtr:outcomeId>CsCuY2BD3Es0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>251697</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Alternative testing cluster SEURAT-1 (Toxbank)</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>BCAD25E1-A732-46A7-BEBA-212FACDE146D</gtr:id><gtr:outcomeId>Cs18ZXfL3890</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EC FP6 EU hESC registry</gtr:description><gtr:end>2010-02-02</gtr:end><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:id>E7F1BADA-BAB9-405F-9E82-E85CE89BA0C5</gtr:id><gtr:outcomeId>rHejL95izKT0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>398223</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>International Stem Cell Forum</gtr:description><gtr:end>2015-07-02</gtr:end><gtr:fundingOrg>International Stem Cell Forum (ISCF)</gtr:fundingOrg><gtr:id>E918E0CA-9223-4024-BA2E-8A514D7E578E</gtr:id><gtr:outcomeId>nGS7K6vdtDf0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>24582</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Tools</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>Technology Strategy Board (TSB)</gtr:fundingOrg><gtr:id>70889A95-5D56-47AD-9892-FB5C3C31E044</gtr:id><gtr:outcomeId>ktmariqJsMd0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Best practice guidance on banking hESC lines for research</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>CD4EF350-850D-411A-87A8-D0324E266A8B</gtr:id><gtr:impact>Principles of best practice publication in Stem Cell Rev Report 2009. Adopted by numerous oprganisations including japanese authorities and Calif Iinst for Regen Med</gtr:impact><gtr:outcomeId>j5V6qNaJzFD</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>National Clinical hESC Forum</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>734F66CC-7327-4499-9CC8-0088D18ED8B9</gtr:id><gtr:impact>Providing best practice guidance for procurment of tissues, processing and testing for development of clinical grade hESC lines
Interaction with HTA HFEA and MHRA has supported a UK proposal for a change in the EU Tissues and Cells Directive in 2012</gtr:impact><gtr:outcomeId>TWAyyBqN4qi</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>hESCreg EC database as an EC tool to register ethically sourced hESC and hiPSC lines</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>210C9D66-CB21-4138-BF1B-67D1CB11C8B1</gtr:id><gtr:impact>Provided listing of international lines proposed for use in EC funded programmes
This site is used by ECommssion to highlight hESC lines considered acceptable for use in EC funded research 
From 2014 registration on website is likely to be a prerequisite for use of lines in EC funded projects
Project has been funded again from January 2016 for 5years</gtr:impact><gtr:outcomeId>SuZGDTZUsLj</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type><gtr:url>http://www.hescreg.eu/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Report to EMA Cell Therapy committee</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>76FF45D2-E715-41DB-A7AD-4027229BFFE5</gtr:id><gtr:impact>Proivision of advice on testing and characterisation of cell therapy products</gtr:impact><gtr:outcomeId>dP58q6jFJeo</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>UK Stem Cell Therapy Road Map</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>81B63DD4-FB49-4A6B-B084-59D1A3FFF7BA</gtr:id><gtr:impact>Clarified regualtory pathways for different stem cell therapeutic products for commercial and healthcare organisations
Highlighted some differences in definitions used by different regulators</gtr:impact><gtr:outcomeId>dgLH25vRKFb</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>hESSCO</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>C55C64B5-A4D9-430D-9E02-461E9F67A68C</gtr:id><gtr:impact>Set best practice guidance for consent for stem cell research</gtr:impact><gtr:outcomeId>tWvxgHV1jZB</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO high level stem cell group</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>6CDDDFC8-5409-4921-9DCD-AAC9DA04B399</gtr:id><gtr:impact>Contruibuted to conclusions of WHO group on stem cells</gtr:impact><gtr:outcomeId>G7sCDtcSXnz</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Version of product developed in International Stem Cell Intitiative made available by ABI to research community</gtr:description><gtr:id>E7B5DC7A-50CC-4567-9B8C-9C071AA6FEB9</gtr:id><gtr:impact>Multiauthor publication in Nature Biotechnology ion 2007 described common characteristics of hESC lines in 17 expert hESC research labs. Reguklar citations.</gtr:impact><gtr:outcomeId>WW6tCnT19hJ</gtr:outcomeId><gtr:stage>Wide-scale adoption</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>ABI Pluripotency gene expression chip</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2007</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>A microfluidics detection system fro multiple pathogenic viruses now available on market from ABI</gtr:description><gtr:id>BCB8C3B2-B739-4D95-BC16-C2C87AF6F6E4</gtr:id><gtr:impact>A detection system available for screening research grade cell ines for viral contamiantion</gtr:impact><gtr:outcomeId>eTP81mk4RPy</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>ABI virus detection card</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>A culture surface treatment to mainrtain stem cell in pluripotent state</gtr:description><gtr:id>807AA07E-27C2-4EAA-8736-5EF8DB1DF5D5</gtr:id><gtr:impact>Data for Orla company to promote further product development</gtr:impact><gtr:outcomeId>aX8696KbRDV</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>Cell culture surface treatments for GMP cell culture</gtr:title><gtr:type>Support Tool - For Medical Intervention</gtr:type><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Well documented source of 3T3 cells provided for use by skin engraftment andf limbal stem cell transplant groups in UK</gtr:description><gtr:id>95C5A733-6721-441E-BE38-3E8E3C04D2D6</gtr:id><gtr:impact>Central source of qualified cells provided for UK health services at request of Department of Health
Now under negotiation of agreements to permit International supply</gtr:impact><gtr:outcomeId>CnjrWGKfsji</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Bank of 3T3 feeder cells for celltherapy</gtr:title><gtr:type>Cell line</gtr:type><gtr:url>http://www.nibsc.org/uk_stem_cell_bank/cell_lines/mefs.aspx</gtr:url><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Banks of ethically sourced and quality controlled humna stem cell lines made available for public research and commercial development</gtr:description><gtr:id>81FE2146-33B9-4765-91B9-80342D0F5004</gtr:id><gtr:impact>Supporting research projects on stem cells for toxicology and and research in c80 other reserch organisations</gtr:impact><gtr:outcomeId>dRsNMV2JQGe</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>human stem cell banks</gtr:title><gtr:type>Cell line</gtr:type><gtr:url>http://www.ukstemcellbank.org.uk</gtr:url><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Standard antibodies ditributed to 17 international labs as part of ISCI project</gtr:description><gtr:id>B98A6D97-8625-444A-A484-6F1A21CA0DAF</gtr:id><gtr:impact>Publication Nat Biotech (2007) and archive of antibodies established at UKSCB</gtr:impact><gtr:outcomeId>Lrx1RAFr5wE</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Antibodies</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://www.stem-cell-forum.net/medical-research-council-uk/</gtr:url><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>MRC-5 bank established in UKSCB cleanroom facilities</gtr:description><gtr:id>0727D145-B7FB-4D5F-B8E9-6406EA25A91D</gtr:id><gtr:impact>Cells with safe history of use inn vaccine manufacture made available to multiple groups for cell therapy development.</gtr:impact><gtr:outcomeId>GWaWHw3y5VM</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>MRC-5 feeder cells for cell therapy</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>6D09DF66-1D16-4891-BF14-79DAF4641496</gtr:id><gtr:title>A call for standardized naming and reporting of human ESC and iPSC lines.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4280060ec3591374d9bd63c90e47433e"><gtr:id>4280060ec3591374d9bd63c90e47433e</gtr:id><gtr:otherNames>Luong MX</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>LMmssCvcLVK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>615FDC0B-5C13-4844-88DD-12729A4A5489</gtr:id><gtr:title>Development of a European human embryonic stem cell registry.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/899beb52f188c0cfff1fa75371a99120"><gtr:id>899beb52f188c0cfff1fa75371a99120</gtr:id><gtr:otherNames>Borstlap J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn><gtr:outcomeId>UT3WMrivu4V</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3AF59EE3-F31B-44D4-9558-6E8F407EF937</gtr:id><gtr:title>Human ES cell lines--introduction.</gtr:title><gtr:parentPublicationTitle>In vitro cellular &amp; developmental biology. Animal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e700d3218da68e511b15f6af3b01375"><gtr:id>3e700d3218da68e511b15f6af3b01375</gtr:id><gtr:otherNames>Andrews PW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1071-2690</gtr:issn><gtr:outcomeId>C7zP3LuPLTa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CEBFC0D-DA39-4137-9216-53B2460B2263</gtr:id><gtr:title>Changing medium and passaging cell lines.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2372c30e67f01fb750e0523a39095d0c"><gtr:id>2372c30e67f01fb750e0523a39095d0c</gtr:id><gtr:otherNames>Masters JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>qwzDiuoSWdJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>705C65DF-2578-4FF3-90AC-D46BB2F7191E</gtr:id><gtr:title>The International Stem Cell Banking Initiative (ISCBI): raising standards to bank on.</gtr:title><gtr:parentPublicationTitle>In vitro cellular &amp; developmental biology. Animal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88a6d005d33b5b918e1129013f74fd10"><gtr:id>88a6d005d33b5b918e1129013f74fd10</gtr:id><gtr:otherNames>Crook JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1071-2690</gtr:issn><gtr:outcomeId>Et8yKLvQyTw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6869605-DD9D-4D44-A41B-3CBE27754668</gtr:id><gtr:title>Environmental monitoring in stem cell banks.</gtr:title><gtr:parentPublicationTitle>Applied microbiology and biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0089b735dd23f3bb8a799148f023da04"><gtr:id>0089b735dd23f3bb8a799148f023da04</gtr:id><gtr:otherNames>Cobo F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0175-7598</gtr:issn><gtr:outcomeId>hndNs6f1ora</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB432B99-F629-4EB7-A310-C4FDF91B2AC2</gtr:id><gtr:title>The changing landscape of European and international regulation on embryonic stem cell research.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a05ab6bb94ef00cb205770fe63c4c6ab"><gtr:id>a05ab6bb94ef00cb205770fe63c4c6ab</gtr:id><gtr:otherNames>Elstner A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>bwnXCh9UbuG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C97CC022-6DFB-4C59-9FD3-44DFCD0A0E26</gtr:id><gtr:title>Stem cell banks: preserving cell lines, maintaining genetic integrity, and advancing research.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/270e04dc44ff42c8eb3fea2cf144d86c"><gtr:id>270e04dc44ff42c8eb3fea2cf144d86c</gtr:id><gtr:otherNames>Healy L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>UP1v3NJPVEm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7072BD46-B1F1-445D-B72D-B2EE5EA8B11F</gtr:id><gtr:title>International banking: checks, deposits, and withdrawals.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae8e1a820a48cd6766e794d864e5bd53"><gtr:id>ae8e1a820a48cd6766e794d864e5bd53</gtr:id><gtr:otherNames>Healy LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>SbLrTYoptuL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>846C9EDD-C9E6-4BE2-B0B9-0452FCDED462</gtr:id><gtr:title>Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes.</gtr:title><gtr:parentPublicationTitle>Stem cell reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/052fa9e8dcc7234174b92e9e3873b7f5"><gtr:id>052fa9e8dcc7234174b92e9e3873b7f5</gtr:id><gtr:otherNames>International Stem Cell Banking Initiative</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1550-8943</gtr:issn><gtr:outcomeId>APYPExcvftg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32F9DFB2-BC01-4227-A648-39D237FD88CC</gtr:id><gtr:title>Cryopreservation and banking of mammalian cell lines.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fde166f056eed9bd4f9f9f3385e39c3c"><gtr:id>fde166f056eed9bd4f9f9f3385e39c3c</gtr:id><gtr:otherNames>Stacey GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>Q1nMdqKwiqw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDC142B3-DD68-4476-8EEF-2C9A75949451</gtr:id><gtr:title>Detection of Mycoplasma in cell cultures.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/172649dab7a38879608fe1416a9530ec"><gtr:id>172649dab7a38879608fe1416a9530ec</gtr:id><gtr:otherNames>Young L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>sCv8J6LkVNj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57660D68-034D-46A7-A175-817EAD08702D</gtr:id><gtr:title>The development of 'feeder' cells for the preparation of clinical grade hES cell lines: challenges and solutions.</gtr:title><gtr:parentPublicationTitle>Journal of biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fde166f056eed9bd4f9f9f3385e39c3c"><gtr:id>fde166f056eed9bd4f9f9f3385e39c3c</gtr:id><gtr:otherNames>Stacey GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0168-1656</gtr:issn><gtr:outcomeId>FukQmpHg9tB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E521FA6-7F28-4102-8612-6FEDB60DE965</gtr:id><gtr:title>Long-term ex situ conservation of biological resources and the role of biological resource centers.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fde166f056eed9bd4f9f9f3385e39c3c"><gtr:id>fde166f056eed9bd4f9f9f3385e39c3c</gtr:id><gtr:otherNames>Stacey GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>oU1TZTbmewv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C5D8AC9-2FCF-42FD-A3C2-AB8036A105BB</gtr:id><gtr:title>Biobanking.</gtr:title><gtr:parentPublicationTitle>Molecular biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2509cf76499ccbfec26dd0751912aa7d"><gtr:id>2509cf76499ccbfec26dd0751912aa7d</gtr:id><gtr:otherNames>Day JG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1073-6085</gtr:issn><gtr:outcomeId>C7Jn1yeZwzr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B936F067-FB9C-4C7E-B642-35114D403E2B</gtr:id><gtr:title>Host cells and cell banking.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fde166f056eed9bd4f9f9f3385e39c3c"><gtr:id>fde166f056eed9bd4f9f9f3385e39c3c</gtr:id><gtr:otherNames>Stacey GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>Up7HcPTom17</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>299276AA-F616-4FAE-824A-5E264601BCBA</gtr:id><gtr:title>Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>In vitro cellular &amp; developmental biology. Animal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72b64f71d4d052e51f62686f045fed98"><gtr:id>72b64f71d4d052e51f62686f045fed98</gtr:id><gtr:otherNames>International Stem Cell Initiative Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1071-2690</gtr:issn><gtr:outcomeId>GVpHNNoxY8A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88ACF447-CB42-4932-988A-3EFC945770DD</gtr:id><gtr:title>The International Stem Cell Initiative: toward benchmarks for human embryonic stem cell research.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e700d3218da68e511b15f6af3b01375"><gtr:id>3e700d3218da68e511b15f6af3b01375</gtr:id><gtr:otherNames>Andrews PW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>mJNVumjjKAB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88D9314E-3A24-47D6-9F4C-1271A6035304</gtr:id><gtr:title>Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac8dda101d738f96423f3e6d8bd9cce1"><gtr:id>ac8dda101d738f96423f3e6d8bd9cce1</gtr:id><gtr:otherNames>International Stem Cell Initiative</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>oC2e5hbfDSJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DC6E9C8-3B4A-49EC-A9C6-882E0F07BF80</gtr:id><gtr:title>First evaluation of the European hESCreg.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/899beb52f188c0cfff1fa75371a99120"><gtr:id>899beb52f188c0cfff1fa75371a99120</gtr:id><gtr:otherNames>Borstlap J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>FFkEHggB226</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45D3A988-B4BB-4EE6-8E4F-6A4B0A82F099</gtr:id><gtr:title>The UK Stem Cell Bank: a UK government-funded, international resource center for stem cell research.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e69578abee6346451f3ce22569cc168d"><gtr:id>e69578abee6346451f3ce22569cc168d</gtr:id><gtr:otherNames>Stacey G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn><gtr:outcomeId>UMhhQgkiRPn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BC15A9F-D760-43B9-971D-2E471F90D5C0</gtr:id><gtr:title>Cell culture contamination.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fde166f056eed9bd4f9f9f3385e39c3c"><gtr:id>fde166f056eed9bd4f9f9f3385e39c3c</gtr:id><gtr:otherNames>Stacey GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>toCABKeUwsw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8A06C63-4A1B-4401-8A78-6FEE213E3461</gtr:id><gtr:title>Microbiological control in stem cell banks: approaches to standardisation.</gtr:title><gtr:parentPublicationTitle>Applied microbiology and biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0089b735dd23f3bb8a799148f023da04"><gtr:id>0089b735dd23f3bb8a799148f023da04</gtr:id><gtr:otherNames>Cobo F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0175-7598</gtr:issn><gtr:outcomeId>mGoZn417AwA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1AFE1AA-042A-40E7-AA3B-D3A14E64323D</gtr:id><gtr:title>Characterization of human embryonic stem cell lines by the International Stem Cell Initiative.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac8dda101d738f96423f3e6d8bd9cce1"><gtr:id>ac8dda101d738f96423f3e6d8bd9cce1</gtr:id><gtr:otherNames>International Stem Cell Initiative</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>VgCcC5rMzS1</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_qA137914</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1A41A859-2076-46E6-B80F-CE4E1E8EDC1D</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>1.5  Resources and infrastructure (underpinning)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>